/
MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

ANAB — AnaptysBio, Inc. Common Stock

Nasdaq

AnaptysBio, Inc. Common Stock

Back to Screener
$48.53
-0.10(-0.21%)
O
48.97
H
49.83
L
48.28
V
440.96K
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

AnaptysBio, Inc. Common Stock Statistics

Total Valuation

Market Cap$1.52B
Enterprise Value$1.51B

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding29.61M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio1,213.25
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ration/a
PEG Ration/a

Enterprise Valuation

EV / Earnings-28.58
EV / Salesn/a
EV / EBITDA-48.17
EV / EBIT-47.25
EV / FCF-58.27

Financial Position

Current Ratio0.76
Quick Ration/a
Debt / Equity9.02
Debt / EBITDA-0.37
Debt / FCF-0.44
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)-4148.74%
Return on Assets (ROA)-160.41%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$-508,500
Employee Count104
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax$40.00K
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+132.28%
50-Day Moving Average$54.98
200-Day Moving Average$48.80
Relative Strength Index (RSI)23.07
Average Volume (20 Days)595,355

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profitn/a
Operating Income-$34.64M
Pretax Income-$52.84M
Net Income-$52.88M
EBITDA-$31.38M
EBIT-$31.98M
Loss Per Share$-1.84

Balance Sheet

Cash & Cash Equivalents$24.85M
Total Debt$11.49M
Net Cash$13.35M
Net Cash Per Share$0.45
Equity (Book Value)$1.27M
Book Value Per Share$0.04
Working Capital-$10.09M

Cash Flow

Operating Cash Flow-$27.41M
Capital Expenditures-$17.00K
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow-$25.94M
FCF Per Share$-0.88

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yieldn/a
FCF Yield-1.70%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a